Page 5 - Findings From News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Findings from. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Findings From Today - Breaking & Trending Today

Disparities in asthma prevalence, attacks, ED use examined during pandemic

Disparities in asthma prevalence, attacks, ED use examined during pandemic
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Adam Gaffney , Findings Froma National , National Health Interview , Cambridge Health Alliance , Health Interview , Asthma Disparities , United States Narrowed During , Findings From , National Survey , Internal Medicine ,

Dr Chari on Findings From the MonumenTAL-1 Trial in Relapsed/Refractory Multiple Myeloma

Ajai Chari, MD, discusses the efficacy of treating patients with less frequent or lower intensity dosing of talquetamab in patients with relapsed/refractory multiple myeloma, as evaluated in the phase 1/2 MonumenTAL-1 study.
....

United States , San Francisco , Myeloma Program , University Of California , Helen Diller Family Comprehensive Cancer Center , Findings From , Refractory Multiple , Multiple Myeloma Program , Diller Family Comprehensive Cancer Center , Ash Annual Meeting And Exposition , Onclive Tv , Multiple Myeloma ,

Keros Therapeutics (KROS) announces additional data from two ongoing Phase 2 clinical trials of KER-050

Keros Therapeutics (KROS) announces additional data from two ongoing Phase 2 clinical trials of KER-050
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Simon Cooper , Jasbirs Seehra , American Society Of Hematology , Keros Therapeutics Inc , Keros Therapeutics , American Society , Annual Meeting , Chief Medical Officer , Total Symptom , Chief Executive , Clinical Benefit , Findings From , Ongoing Phase , Reduced Iron Overload , Increased Bone Specific Alkaline Phosphatase , Restore Balance , Superfamily Signaling , Treat Myelofibrosis , Mitigate Ruxolitinib Associated , Total Symptom Score ,

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

San Diego , United States , Simon Cooper , Jasbirs Seehra , Justin Frantz , American Society Of Hematology , Exchange Commission , Keros Therapeutics Inc , American Society Of Hematology Annual Meeting , Company Quarterly Report On Form , Therapeutics Presents Clinical Data , American Society , Hematology Annual Meeting , Keros Therapeutics , Annual Meeting , Chief Medical Officer , Total Symptom , Chief Executive , Clinical Benefit , Findings From , Ongoing Phase , Reduced Iron Overload , Increased Bone Specific Alkaline Phosphatase , Restore Balance , Superfamily Signaling , Treat Myelofibrosis ,

Keros Therapeutics, Inc. Presents Clinical Data from its KER-050 Program at the 65th American Society of Hematology Annual Meeting and Exposition

Keros Therapeutics, Inc. announced that it presented additional data from its two ongoing Phase 2 clinical trials of KER-050, one in patients with very low-, low-, or intermediate-risk myelodysplastic. ....

San Diego , United States , American Society Of Hematology , Keros Therapeutics Inc , Keros Therapeutics , American Society , Annual Meeting , Durable Clinical Benefit , Findings From , Ongoing Phase , Superfamily Signaling ,